2m 2m 2m 2m 2m 2m 2m
KORRO BIO (KRRO)
NASDAQ
$10.40+$0.03 (+0.24%)
Price as of Jul 31, 2026 7:34 PM EDT- $149.6MMarket Cap
- -25.13%1-Year Change
- BiotechnologyIndustry
KORRO BIO (KRRO)
$10.40+$0.03 (+0.24%)
KRRO | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.37 | ||
Change | -$0.08 (-0.77%) | ||
Open | $10.53 | ||
High | $10.53 | ||
Low | $9.76 | ||
Previous Close | $10.45 | ||
Volume | 115,192 | ||
30-Day Average Volume | 193,273 | ||
1-Week Change | -2.54% | ||
1-Month Change | -21.32% | ||
1-Year Change | -25.13% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 14.4M | ||
Total Assets | $183.6M | ||
Market Cap | $149.6M | ||
Enterprise Value | $87.9M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$19.6M | ||
Free Cash Flow | -$16.1M | ||
EBIT | -$19.5M | ||
EBITDA | -$19.1M | ||
Net Working Capital | $105.4M | ||
EPS | -$1.69 | ||
Enterprise Value/EBITDA | -5 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 1 | ||
P/E | -6 | ||
PEG | -0 | ||
Price/Free Cash Flow | -9 | ||
Price/Operating Cash Flow | -9 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue